Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 4 ( April, 2021 ) > List of Articles

LETTER TO EDITOR

Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19

Abhyuday Kumar, Dharani Lenin, Shaheen Ahmad

Citation Information : Kumar A, Lenin D, Ahmad S. Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19. Indian J Crit Care Med 2021; 25 (4):474-475.

DOI: 10.5005/jp-journals-10071-23794

License: CC BY-NC 4.0

Published Online: 01-04-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Nair P, Melarkode R, Rajkumar D, Montero E. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction. Clin Exp Immunol 2010;162(1):116–130. DOI: 10.1111/j.1365-2249.2010.04235.x.
  2. Ministry of Health and Family Welfare, India. DCGI gives Nod for restricted emergency use to Itolizumab for moderate to severe COVID-19 patients. Press release. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1637926. Accessed 22 December 2020.
  3. Lenz HJ. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007;12(5):601–609. DOI: 10.1634/theoncologist.12-5-601.
  4. Vogel WH. Infusion reactions: diagnosis, assessment, and management. Clin J Oncol Nurs 2010;14(2):E10–E21. DOI: 10.1188/10.CJON.E10-E21.
  5. Poterucha JT, Westberg M, Nerheim P, Lovell JP. Rituximab-induced polymorphic ventricular tachycardia. Tex Heart Inst J 2010;37(2):218–220. PMID: 20401299. PMCID: PMC2851419.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.